In fairly big news for patent litigants in the US, the Federal Circuit recently clarified that you can rely on prior art in the patent litigation, even if you have relied...

US Copyright Office released a controversial report on AI impact on copyright and then one day later Trump fired the Director, Shira Perlmutter. A key finding of the report was that...

The global dispute between Amgen and Sanofi over patent claims to Amgen’s drug Repatha® (evoloumab) saw another chapter close on 24 April. In this installment, the Australian Federal Court dismissed Sanofi’s...

Trending in intellectual property at the moment: Apple ordered to pay US $502m plus compound interest to non practicing entity Optis in FRAND patent infringement appeal to UK Court of Appeal....

Here’s a quick update on recent and important IP issues. You still need to clear the way in UK pharma patent cases. Loss of first mover advantage still holds great weight....

In the early stages of patent infringement proceedings, each of the respondents (defendants) argued that Scidera had not put its case sufficiently clearly to the court in its pleadings (Statement of...

List key markets in size order. Add countries where competitors will manufacture. Add other particularly important countries for logistics – eg. is there a country that everyone will have to transit...

How do you protect your IP Processes?  More importantly, have you ever done a freedom to operate clearance on them? To kick off this short series of posts, here are a...

Thanks to Taylor Wessing’s brand new Patent Map, anyone can now quickly compare European jurisdictions on key litigation factors. Those who have litigated in Europe will know that this comparison is...

It doesn’t really matter how strategic you think you are, if you can’t access a pragmatic and clear construction of patent claims, you’re in trouble. While patent terms always come back...